Molly Carr
CIK: 0002147544
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IBIO
iBio, Inc.
Officer
Discretionary Trading P&L
Holdings
About Carr Molly
Carr Molly (SEC CIK 0002147544) files insider reports with the SEC as Chief Medical Officer of iBio, Inc. (IBIO).
Signal8 holds 2 ownership filings by Carr Molly (1 Form 3, 1 Form 4), filed on Aug 4, 2026. Those filings report 1 transaction, the latest on Jul 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Carr Molly's filings is in SAN DIEGO, CA.
Recent filings by Carr Molly
- Jul 31, 2026: Grant or award of IBIO derivative securities (Form 4, code A).
Other insiders filing for iBio, Inc. (IBIO)
- Stoner Elizabeth, Director
- Kropotova Alexandra, Director
- Arkowitz David, Director
- Clark William D, Director
- Parada Antonio Bernardino Guimaraes, Director
- Sender Gary, Director